Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARS-CoV-2 Vaccination, Japan. Sato T, Kodama S, Kaneko K, Imai J, et al. Emerg Infect Dis 2022;28.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sato T, Kodama S, Kaneko K, Imai J, et al. Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARS-CoV-2 Vaccination, Japan. Emerg Infect Dis 2022;28.
PMID: 35468049